Guobang Pharma Ltd. (605507.SS)

CNY 20.45

(0.34%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 10.36 Billion 9.04 Billion 7.51 Billion 5.5 Billion 4.75 Billion 4.36 Billion
Total Current Assets 5.44 Billion 5.12 Billion 4.56 Billion 2.87 Billion 2.76 Billion 2.83 Billion
Cash And Short Term Investments 2.56 Billion 2.79 Billion 2.15 Billion 1.23 Billion 1.26 Billion 1 Billion
Cash and Cash Equivalents 2.09 Billion 1.97 Billion 893 Million 1.23 Billion 1.11 Billion 1 Billion
Short Term Investments 465.98 Million 824.55 Million 1.25 Billion 34.78 Thousand 149.87 Million -
Net Receivables 1.47 Billion 852.41 Million 1.06 Billion 618.12 Million 611.74 Million 624.9 Million
Inventory 1.36 Billion 1.4 Billion 1.3 Billion 989.54 Million 846.72 Million 868.93 Million
Other Current Assets 40.04 Million 69.15 Million 40.4 Million 28.86 Million 37.27 Million 336.73 Million
Total Non-Current Assets 4.91 Billion 3.91 Billion 2.94 Billion 2.63 Billion 1.99 Billion 1.53 Billion
Net PPE 4.33 Billion 3.28 Billion 2.62 Billion 2.15 Billion 1.45 Billion 1.17 Billion
Good Will And Intangible Assets 358.87 Million 370.52 Million 272.29 Million 266.73 Million 274.56 Million 156.41 Million
Good Will 25.48 Thousand 25.48 Thousand 25.48 Thousand 25.48 Thousand 25.48 Thousand 25.48 Thousand
Intangible Assets 358.84 Million 370.49 Million 272.26 Million 266.7 Million 274.54 Million 156.38 Million
Long-Term Investments -344.86 Million -723.19 Million -1.24 Billion 18.63 Million -129.87 Million 142.1 Million
Tax Assets 7.77 Million 6.58 Million 19.01 Million 12.01 Million 11.91 Million 20.01 Million
Other Non Current Assets 566.65 Million 976.43 Million 1.27 Billion 187.92 Million 386.47 Million 36.81 Million
Other Assets - 1.00 - 1.00 1.00 -
Total Liabilities 2.92 Billion 1.88 Billion 1.16 Billion 2.23 Billion 2.14 Billion 1.77 Billion
Total Current Liabilities 2.44 Billion 1.86 Billion 1.15 Billion 1.97 Billion 1.57 Billion 1.71 Billion
Account Payables 1.71 Billion 974.34 Million 789.7 Million 1.09 Billion 920.7 Million 907.57 Million
Tax Payables 34.22 Million 17.98 Million 43.31 Million 34.65 Million 38.46 Million 92.2 Million
Short Term Debt 511.56 Million 655.56 Million 160.16 Million 659.65 Million 417.94 Million 581.12 Million
Deferred Revenue 218.81 Million 52.79 Million 200.38 Million 214.06 Million 200.18 Million 92.2 Million
Other Current Liabilities 4.62 Million 179.67 Million 3.24 Million 3 Million 35 Million 135.01 Million
Total Non Current Liabilities 474.82 Million 26.19 Million 13.86 Million 261.96 Million 569.68 Million 58.64 Million
Long-Term Debt 451.7 Million - - 251 Million 482.65 Million 27 Million
Deferred Revenue Non Current 11.79 Million 14.26 Million 9.7 Million 8.27 Million 9.3 Million 10.34 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - 1.00 - - 74.36 Million 18.44 Million
Other Liabilities 1.00 1.00 1.00 1.00 - -
Total Equity 7.43 Billion 7.15 Billion 6.34 Billion 3.27 Billion 2.61 Billion 2.59 Billion
Stock Holders Equity 7.43 Billion 7.15 Billion 6.34 Billion 3.27 Billion 2.61 Billion 1.24 Billion
Common Stock 558.82 Million 558.82 Million 558.82 Million 475 Million 475 Million 75.97 Million
Retained Earnings 3.08 Billion 2.84 Billion 2.05 Billion 1.72 Billion 1.07 Billion 1.1 Billion
Accumulated other comprehensive income 183.83 Million 3.74 Billion 124.54 Million 50.38 Million 1.06 Billion 70.61 Million
Common Stock Equity 7.43 Billion 7.15 Billion 6.34 Billion 3.27 Billion 2.61 Billion 1.24 Billion
Capital Lease Obligation - - - - - -
Total Investments 121.12 Million 101.36 Million 17.11 Million 18.67 Million 19.99 Million 142.1 Million
Total Debt 963.26 Million 655.56 Million 160.16 Million 910.65 Million 900.6 Million 608.12 Million
Net Debt -1.13 Billion -1.31 Billion -732.84 Million -323.94 Million -214.2 Million -393.79 Million

Balance Sheet Charts